|
Documents can be downloaded from the DFID Website.
1. Montgomery CM, Lees S, Stadler J, et al. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care 2008;20:733-40.
2. Allen CF, Lees SS, Desmond NA, et al. Validity of coital diaries in a feasibility study for the Microbicides Development Programme trial among women at high risk of HIV/AIDS in Mwanza, Tanzania. Sex Transm Infect 2007;83:490-6; discussion 6-7.
3. Ndinda C, Chimbwete C, McGrath N, Pool R, Mdp G. Community attitudes towards individuals living with HIV in rural KwaZulu-Natal, South Africa. AIDS Care 2007;19:92-101.
4. Ndinda C, Uzodike UO, Chimbwete C, Pool R. Gender relations in the context of HIV/AIDS in rural South Africa. AIDS Care 2007;19:844-9.
5. Stadler JJ, Delany S, Mntambo M. Sexual coercion and sexual desire: ambivalent meanings of heterosexual anal sex in Soweto, South Africa. AIDS Care 2007;19:1189-93.
6. Vallely A, Shagi C, Kasindi S, et al. The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania. BMC Public Health 2007;7:133.
7. Vallely A, Kasindi S, Hambleton IR, et al. Microbicides development program, Tanzania-baseline characteristics of an occupational cohort and reattendance at 3 months. Sex Transm Dis 2007;34:638-43.
8. Beer BE, Doncel GF, Krebs FC, et al. In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories. Antimicrob Agents Chemother 2006;50:713-23.
9. Fletcher PS, Wallace GS, Mesquita PM, Shattock RJ. Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants. Retrovirology 2006;3:46.
10. Fletcher PS, Elliott J, Grivel JC, et al. Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides. AIDS 2006;20:1237-45.
11. Klasse PJ, Shattock RJ, Moore JP. Which topical microbicides for blocking HIV-1 transmission will work in the real world? PLoS Med 2006;3:e351.
12. Lacey CJ, Wright A, Weber JN, Profy AT. Direct measurement of in-vivo vaginal microbicide levels of PRO 2000 achieved in a human safety study. AIDS 2006;20:1027-30.
13. Lees SS, Desmond N, Allen C, Bugeke G, Vallely A, Ross DA. Women’s agency in sexual negotiation and HIV prevention in Mwanza, Tanzania: Considerations for the acceptability of vaginal microbicides (Microbicides Development Programme). 2006.
14. Sexton A, Drake PM, Mahmood N, Harman SJ, Shattock RJ, Ma JK. Transgenic plant production of Cyanovirin-N, an HIV microbicide. FASEB J 2006;20:356-8.
15. Terris-Prestholt F, Kumaranayake L, Obasi AI, et al. From trial intervention to scale-up: costs of an adolescent sexual health program in Mwanza, Tanzania. Sex Transm Dis 2006;33:S133-9.
16. Terris-Prestholt F, Kumaranayake L, Foster S, et al. The role of community acceptance over time for costs of HIV and STI prevention interventions: analysis of the Masaka Intervention Trial, Uganda, 1996-1999. Sex Transm Dis 2006;33:S111-6.
17. Vickerman P, Watts C. Interpreting Phase III microbicide trials that show a significant reduction in HIV incidence and STI prevalence: model insights 2006.
18. Vickerman P, Terris-Prestholt F, Delany S, Kumaranayake L, Rees H, Watts C. Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa. Sex Transm Dis 2006;33:S122-32.
19. Vickerman P, Watts C, Delany S, Alary M, Rees H, Heise L. The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settings. Sex Transm Dis 2006;33:397-405.
20. Bakobaki JM, Lacey CJ, Bukenya MI, et al. A randomized controlled safety and acceptability trial of dextrin sulphate vaginal microbicide gel in sexually active women in Uganda. AIDS 2005;19:2149-56.
21. McCormack J, Loewen P, Jewesson P. Dissemination of results needs to be tracked as well as the funding is. BMJ 2005;331:456.
22. McCormack S, Jespers V, Low-Beer N, et al. A dose-ranging phase I study of dextrin sulphate, a vaginal microbicide, in HIV-negative and HIV-positive female volunteers. Sex Transm Dis 2005;32:765-70.
23. Veazey RS, Klasse PJ, Schader SM, et al. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 2005;438:99-102.
24. Watson-Jones D, Oliff M, Terris-Prestholt F, et al. Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania. Trop Med Int Health 2005;10:934-43.
25. Weber J, Desai K, Darbyshire J. The development of vaginal microbicides for the prevention of HIV transmission. PLoS Med 2005;2:e142.
26. Hu Q, Frank I, Williams V, et al. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J Exp Med 2004;199:1065-75.
27. Tsai CC, Emau P, Jiang Y, et al. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res Hum Retroviruses 2004;20:11-8.
28. Moore JP, Shattock RJ. Preventing HIV-1 sexual transmission--not sexy enough science, or no benefit to the bottom line? J Antimicrob Chemother 2003;52:890-2.
29. Shattock RJ, Moore JP. Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 2003;1:25-34.
30. Veazey RS, Shattock RJ, Pope M, et al. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med 2003;9:343-6.
31. Low-Beer N, Gabe R, McCormack S, Kitchen VS, Lacey CJ, Nunn AJ. Dextrin sulfate as a vaginal microbicide: randomized, double-blind, placebo-controlled trial including healthy female volunteers and their male partners. J Acquir Immune Defic Syndr 2002;31:391-8.
32. McCormack S. Vaginal microbicides. Curr Opin Infect Dis 2002;15:57-62.
33. Shattock RJ, Doms RW. AIDS models: microbicides could learn from vaccines. Nat Med 2002;8:425.
34. McCormack S, Hayes R, Lacey CJ, Johnson AM. Microbicides in HIV prevention. BMJ 2001;322:410-3.
35. Weber J, Nunn A, O'Connor T, et al. 'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo. AIDS 2001;15:1563-8.
36. Van Damme L, Wright A, Depraetere K, et al. A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women. Sex Transm Infect 2000;76:126-30.
|
